K. Obata

Growth hormone therapy and scoliosis in patients with Prader–Willi syndrome

N. Niikawa, R. Sakuta, T. Ogata, 2006, American journal of medical genetics. Part A.

Effects of 5 Years Growth Hormone Treatment in Patients with Prader-Willi Syndrome

R. Sakuta, A. Yoshino, K. Obata, 2003, Journal of pediatric endocrinology & metabolism : JPEM.

Characterization of fat distribution in Prader–Willi syndrome: Relationships with adipocytokines and influence of growth hormone treatment

H. Itabashi, Yuriko Tanaka, T. Nagai, 2013, American journal of medical genetics. Part A.

Postnatal overgrowth by 15q-trisomy and intrauterine growth retardation by 15q-monosomy due to familial translocation t(13;15): dosage effect of IGF1R?

N. Niikawa, R. Sakuta, N. Matsumoto, 2002, American journal of medical genetics.

Scoliosis in Prader–Willi syndrome: Effect of growth hormone therapy and value of paravertebral muscle volume by CT in predicting scoliosis progression

H. Itabashi, Yuriko Tanaka, T. Tsuchiya, 2012, American journal of medical genetics. Part A.

Characterization of Diabetes Mellitus in Japanese Prader-Willi Syndrome

T. Tsuchiya, T. Nagai, K. Obata, 2011, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

Cause of sudden, unexpected death of Prader–Willi syndrome patients with or without growth hormone treatment

N. Niikawa, R. Sakuta, H. Tonoki, 2005, American journal of medical genetics. Part A.

Testosterone replacement therapy to improve secondary sexual characteristics and body composition without adverse behavioral problems in adult male patients with Prader–Willi syndrome: An observational study

H. Itabashi, Yuriko Tanaka, T. Nagai, 2013, American Journal of Medical Genetics. Part A.

Bromocriptine treatment of prolactinoma restores growth hormone secretion and causes catch-up growth in a prepubertal child

R. Sakuta, T. Nagai, A. Yoshino, 2004, European Journal of Pediatrics.

Membranoproliferative glomerulonephritis in a patient with X-linked agammaglobulinemia

H. Kanegane, T. Miyawaki, Y. Ueda, 2005, Pediatric Nephrology.

Exacerbation of BMI after cessation of growth hormone therapy in patients with Prader–Willi syndrome

Yuriko Tanaka, T. Tsuchiya, T. Nagai, 2014, American journal of medical genetics. Part A.

Growth hormone secretion and its effect on height in pediatric patients with different genotypes of Prader–Willi syndrome

T. Ogata, T. Tsuchiya, T. Nagai, 2012, American journal of medical genetics. Part A.